8-K current report · filed Oct 21, 2026

CME Group (CME) 8-K Current Report: October 21, 2026

Item 2.02Item EX-99.19CME overview

Short answer

CME Group (CME) filed an 8-K current report with the SEC on October 21, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.19 (Exhibit EX-99.19). Q3 2026 results for quarter ended September 30, 2026, released October 21, 2026.

CME Group 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q3 2026 results for quarter ended September 30, 2026, released October 21, 2026
  • Exhibit 99.1 contains CME’s financial results and investor-relevant operating performance details
  • Non-GAAP revenue, expenses, operating income, net income and EPS supplement GAAP results
  • Non-GAAP reconciliation enables comparison with prior financial reports, though adjustments may include recurring items

Item EX-99.19 · Exhibit EX-99.19

  • Q3 2026 revenue reached a record $1.7B, up from $1.5B, with net income rising to $1.0B
  • Adjusted diluted EPS $3.02 versus $2.68, highlighting earnings growth beyond reported GAAP results
  • Record ADV of 29.4M contracts, with double-digit growth across all six asset classes, supporting transaction-fee momentum
  • Market data revenue rose 20% to a record $243M, strengthening recurring revenue diversification
  • Nearly $1B returned to shareholders: $465M dividends and $524M repurchases

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other CME Group 8-K filings

Get the next CME 8-K as it lands

Follow CME for push alerts, or ask the research agent what this filing means.